People · Operator
Named in public records as an officer, director or promoter · active 2023–2024 · Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Visibly, Inc. | — | Other Technology | Series B | $49.2M | $289.5M | 2023 |
| Third Pole, Inc. | — | Other Technology | Series B | $43.1M | $139.4M | 2024 |
| S4 Medical Corp. | — | Biotechnology | Series A | $12.0M | $49.6M | 2023 |
Hirak Parikh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hirak Parikh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Hirsch | 1 | 19 |
| Steven Lee | 1 | 9 |
| Jeffrey McCormick | 1 | 6 |
| Roy Tanaka | 1 | 6 |
| Werner Cautreels | 1 | 5 |
| V. Kadir Kadhiresan | 1 | 5 |
| Ashleigh Palmer | 1 | 4 |
| Garrett Vygantas | 1 | 4 |
| Paul Foley | 1 | 4 |
| Salen Churi | 1 | 4 |
| Kadir Kadhiresan | 1 | 4 |
| Bill Baumel | 1 | 3 |
| David Ting | 1 | 2 |
| Brent Rasmussen | 1 | 2 |
| Kunal Paymaster | 1 | 2 |
| William Fuller | 1 | 2 |
| Aaron Dallek | 1 | 2 |
| Scott Axonovitz | 1 | 2 |
| Lori McInerney | 1 | 1 |
| David Zapol | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.